Contact

Representative before the EPO

Employment test 51 - 200 employees
Company dna mewburn ellis llp
operating since 1890
Headquarter in London and 4 offices
active in Legal Services

We have observed 66 EP applications Wilhelmus Johannes Wytenburg has served for within the last five+ years. (We consider all applications which have an EP A1 publication dated after January 16, 2013). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP12709201

CRYSTALLINE FORMS AND PROCESSES FOR THE PREPARATION OF CONDENSED AZACYCLES ( CANNABINOID RECEPTOR MODULATORS)

IPC classification:
A61P 29/00, C07D 403/04, A61K 31/416
Agent:
Wilhelmus Johannes Wytenburg, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP12716763

CANNABINOID RECEPTOR MODULATORS

IPC classification:
A61P 29/00, C07D 231/54, C07D 401/04, C07D 401/14, C07D 403/04, C07D 405/14, C07F 9/09, A61K 31/416, A61K 31/4439, A61K 31/497, A61K 31/661
Agent:
Wilhelmus Johannes Wytenburg, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP12786332

QUINAZOLINE-7-ETHER COMPOUNDS AND METHODS OF USE

IPC classification:
A61P 35/00, C07D 405/12, C07D 493/04, A61K 31/517
Agent:
Wilhelmus Johannes Wytenburg, Mewburn Ellis LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12792550

TRICYCLIC INHIBITORS OF POLY(ADP-RIBOSE)POLYMERASE

IPC classification:
A61P 9/10, A61P 29/00, A61P 35/00, C07F 9/6584, A61K 31/395
Agent:
Wilhelmus Johannes Wytenburg, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP12844804

PAK INHIBITORS FOR THE TREATMENT OF CELL PROLIFERATIVE DISORDERS

IPC classification:
A61P 35/00, C07D 403/10, C07D 405/14, C07D 471/04, A61K 31/519
Agent:
Wilhelmus Johannes Wytenburg, Mewburn Ellis LLP
Status:
APPLICATION REFUSED
EP12845870

PAK INHIBITORS FOR THE TREATMENT OF FRAGILE X SYNDROME

IPC classification:
A61P 25/00, C07D 401/10, C07D 471/04, A61K 31/519
Agent:
Wilhelmus Johannes Wytenburg, Mewburn Ellis LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12784666

5-(PYRIDIN-2-YL-AMINO)-PYRAZINE-2-CARBONITRILE COMPOUNDS AND THEIR THERAPEUTIC USE

IPC classification:
A61P 35/00, C07D 401/12, C07D 401/14, A61K 31/497
Applicant:
Cancer Research Technology Ltd
Agent:
Wilhelmus Johannes Wytenburg, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP12859248

GUANINE ANALOGS AS TELOMERASE SUBSTRATES AND TELOMERE LENGTH AFFECTORS

IPC classification:
A61P 35/00, A61P 35/02, A61P 35/04, C07F 9/6561, A61K 31/675, A61K 31/683, A61K 31/685, A61K 31/688
Agent:
Wilhelmus Johannes Wytenburg, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP13738359

BENZOHETEROCYCLIC COMPOUNDS AND USE THEREOF

IPC classification:
A61P 29/00, A61P 35/00, C07D 209/02, C07D 231/54, C07D 263/54, C07D 277/62, C07D 285/14, A61K 31/41, A61K 31/42, A61K 31/425, A61K 31/433
Agent:
Wilhelmus Johannes Wytenburg, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP12787319

MODULATORS OF THE G PROTEIN-COUPLED MAS RECEPTOR AND THE TREATMENT OF DISORDERS RELATED THERETO

IPC classification:
A61P 9/00, C07D 241/04, A61K 31/496
Agent:
Wilhelmus Johannes Wytenburg, Mewburn Ellis LLP
Status:
APPLICATION WITHDRAWN
EP14173149

Therapeutic compounds

IPC classification:
A61P 25/20, C07C 37/055, C07C 39/06, C07C 271/44, A61K 31/05
Agent:
Wilhelmus Johannes Wytenburg, Mewburn Ellis LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13704701

MORPHOLINOALKYL FUMARATE COMPOUNDS, PHARMACEUTICAL COMPOSITIONS, AND METHODS OF USE

IPC classification:
A61P 25/00, A61P 29/00, A61P 37/00, C07D 265/30, A61K 31/42
Agent:
Wilhelmus Johannes Wytenburg, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP13709994

3-ARYL-5-SUBSTITUTED-ISOQUINOLIN-1-ONE COMPOUNDS AND THEIR THERAPEUTIC USE

IPC classification:
A61P 35/00, C07D 217/14, C07D 217/16, C07D 401/04, C07D 401/10, C07D 401/12, C07D 401/14, C07D 405/12, C07D 487/04, C07D 487/08, C07D 487/10, A61K 31/472, A61K 31/4725, A61K 31/496, A61K 31/506
Agent:
Wilhelmus Johannes Wytenburg, Mewburn Ellis LLP
Status:
PATENT GRANTED
EP13768915

PHENYL-UREA AND PHENYL-CARBAMATE DERIVATIVES AS INHIBITORS OF PROTEIN AGGREGATION

IPC classification:
A61K 31/17, A61K 31/27
Agent:
Wilhelmus Johannes Wytenburg, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP13773141

PROTEIN KINASE C INHIBITORS AND USES THEREOF

IPC classification:
A01N 43/40, A61K 31/445, A61K 31/505, A61K 31/535
Applicant:
Rigel Pharmaceuticals Inc
Agent:
Wilhelmus Johannes Wytenburg, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP13723910

5-[[4-[[MORPHOLIN-2-YL]METHYLAMINO]-5-(TRIFLUOROMETHYL)-2-PYRIDYL]AMINO]PYRAZINE-2-CARBONITRILE AND THERAPEUTIC USES THEREOF

IPC classification:
A61P 35/00, C07D 401/12, A61K 31/506
Applicant:
Cancer Research Technology Ltd
Agent:
Wilhelmus Johannes Wytenburg, Mewburn Ellis LLP
Status:
PATENT GRANTED
EP13729851

TREATMENT OF MULTIPLE SCLEROSIS AND PSORIASIS USING PRODRUGS OF METHYL HYDROGEN FUMARATE

IPC classification:
A61P 17/06, A61P 25/00, C07C 235/14, C07D 207/02, C07D 295/104, A61K 31/265, A61K 31/5375
Agent:
Wilhelmus Johannes Wytenburg, Mewburn Ellis LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP14182803

Modulators of the prostacyclin (PG12) receptor useful for the treatment of disorders related thereto

IPC classification:
A61P 43/00, C07C 271/08, C07C 275/18, A61K 31/17, A61K 31/27
Agent:
Wilhelmus Johannes Wytenburg, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP13816903

PREVENTION OF ALCOHOL REACTION WITH DIETARY SUPPLEMENTS

IPC classification:
A23L 1/30, A61K 31/122
Agent:
Wilhelmus Johannes Wytenburg, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP13820320

DI-AND TRI-HETEROARYL DERIVATIVES AS INHIBITORS OF PROTEIN AGGREGATION

IPC classification:
A61K 31/496
Agent:
Wilhelmus Johannes Wytenburg, Mewburn Ellis LLP
Status:
The patent has been granted
EP13756971

METHODS OF ADMINISTERING MONOMETHYL FUMARATE AND PRODRUGS THEREOF HAVING REDUCED SIDE EFFECTS

IPC classification:
A61P 17/06, A61P 25/00, A61P 29/00, A61K 9/28, A61K 31/225, A61K 31/5375
Agent:
Wilhelmus Johannes Wytenburg, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP13759076

ORAL DOSAGE FORMS OF METHYL HYDROGEN FUMARATE AND PRODRUGS THEREOF

IPC classification:
A61P 17/06, A61P 25/00, A61P 29/00, A61K 9/16, A61K 9/28, A61K 31/225, A61K 31/5375
Agent:
Wilhelmus Johannes Wytenburg, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP13756261

ORAL DOSAGE FORMS OF METHYL HYDROGEN FUMARATE AND PRODRUGS THEREOF

IPC classification:
A61P 17/06, A61P 25/00, A61P 29/00, A61K 9/16, A61K 9/28, A61K 31/225, A61K 31/5375
Agent:
Wilhelmus Johannes Wytenburg, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP11729441

(R)-1,2-PROPANEDIOL FOR USE AS A SOLVENT IN THERAPEUTIC COOLING AGENT COMPOSITIONS

IPC classification:
A61P 11/00, A61P 17/04, A61K 31/223, A61K 47/10
Agent:
Wilhelmus Johannes Wytenburg, Mewburn Ellis LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13805533

COMBINATION THERAPY USING BELINOSTAT AND TRABECTEDIN

IPC classification:
A61K 31/196, A61K 31/4995, A61K 45/06
Agent:
Wilhelmus Johannes Wytenburg, Mewburn Ellis LLP
Status:
APPLICATION WITHDRAWN
EP13853588

COMPOUNDS AND METHODS FOR PRODUCING A CONJUGATE

IPC classification:
A61K 31/4152, A61K 39/00
Agent:
Wilhelmus Johannes Wytenburg, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP13855289

HYDRAZINYL-INDOLE COMPOUNDS AND CONJUGATES

IPC classification:
C07D 403/00
Agent:
Wilhelmus Johannes Wytenburg, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP13859485

INHIBITOR OF APOPTOSIS PROTEIN (IAP) ANTAGONISTS

IPC classification:
A61P 35/00, C07D 487/04, C07D 498/04, A61K 31/5365
Agent:
Wilhelmus Johannes Wytenburg, Mewburn Ellis LLP
Agent:
HGF Limited
Status:
GRANT OF PATENT INTENDED
EP13812297

PROTEIN KINASE C INHIBITORS AND USES THEREOF

IPC classification:
C07D 455/02
Applicant:
Rigel Pharmaceuticals Inc
Agent:
Wilhelmus Johannes Wytenburg, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP14701137

BIPHENYL-ETHYL-PYRROLIDINE DERIVATIVES AS HISTAMINE H3 RECEPTOR MODULATORS FOR THE TREATMENT OF COGNITIVE DISORDERS

IPC classification:
A61P 3/04, A61P 25/04, A61P 25/08, A61P 25/18, A61P 25/24, A61P 25/28, A61P 37/08, C07D 257/04, C07D 295/14, A61K 31/40, A61K 31/4025, A61K 31/41
Agent:
Wilhelmus Johannes Wytenburg, Mewburn Ellis LLP
Agent:
Schiweck Weinzierl Koch Patentanwälte Partnerschaft mbB
Status:
EXAMINATION IN PROGRESS
EP15156493

Combination therapy using an HDAC inhibitor and Vincristine for treating cancer

IPC classification:
A61P 35/00, A61K 31/138, A61K 31/18, A61K 31/196, A61K 31/198, A61K 31/24, A61K 31/337, A61K 31/4745, A61K 31/475, A61K 31/513, A61K 31/517, A61K 31/519, A61K 31/555, A61K 31/573, A61K 31/706, A61K 31/7068, A61K 31/7076, A61K 33/24, A61K 45/06
Agent:
Wilhelmus Johannes Wytenburg, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP14729498

PROTEIN KINASE C INHIBITORS AND USES THEREOF

IPC classification:
A61P 35/00, C07D 471/04, A61K 31/437
Applicant:
Rigel Pharmaceuticals Inc
Agent:
Wilhelmus Johannes Wytenburg, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP14725519

FLUORO-PERHEXILINE COMPOUNDS AND THEIR THERAPEUTIC USE

IPC classification:
A61P 9/04, C07D 211/38, A61K 31/445
Applicant:
The University Court of The University of Aberdeen
Agent:
Wilhelmus Johannes Wytenburg, Mewburn Ellis LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP14733041

CORTICOSTEROID COMPOSITIONS

IPC classification:
A61K 9/06, A61K 31/56, A61K 31/57, A61K 31/573, A61K 31/58, A61K 47/14
Agent:
Wilhelmus Johannes Wytenburg, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP14735642

N-(4-HYDROXY-4-METHYL-CYCLOHEXYL)-4-PHENYL-BENZENESULFONAMIDES AND N-(4-HYDROXY-4-METHYL-CYCLOHEXYL)-4-(2-PYRIDYL)BENZENESULFONAMIDES AND THEIR THERAPEUTIC USE

IPC classification:
A61P 29/00, C07C 311/20, C07D 213/61, A61K 31/18, A61K 31/4418
Agent:
Wilhelmus Johannes Wytenburg, Mewburn Ellis LLP
Status:
PATENT GRANTED
EP14753395

METHODS OF ADMINISTERING MONOMETHYL FUMARATE AND PRODRUGS THEREOF HAVING REDUCED SIDE EFFECTS

IPC classification:
C12Q 1/48, C12Q 1/68, A61K 31/215, A61K 31/225
Agent:
Wilhelmus Johannes Wytenburg, Mewburn Ellis LLP
Status:
APPLICATION WITHDRAWN
EP14772500

CRYSTALLINE FORMS OF (N,N-DIETHYLCARBAMOYL)METHYL METHYL (2E)BUT-2-ENE-1,4-DIOATE, METHODS OF SYNTHESIS AND USE

IPC classification:
A61P 3/10, A61P 11/06, A61P 17/06, A61P 25/28, A61P 29/00, A61P 31/12, A61P 31/18, A61P 31/22, C07C 235/06, A61K 31/225
Agent:
Wilhelmus Johannes Wytenburg, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP14781338

LIQUID PROTEIN FORMULATIONS CONTAINING ORGANOPHOSPHATES

IPC classification:
C07K 1/14, A61K 9/00, A61K 9/19, A61K 38/00, A61K 39/00, A61K 47/18, A61K 47/20
Agent:
Wilhelmus Johannes Wytenburg, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP14781337

LIQUID PROTEIN FORMULATIONS CONTAINING WATER SOLUBLE ORGANIC DYES

IPC classification:
C07K 1/14, A61K 9/00, A61K 9/08, A61K 9/19, A61K 38/00, A61K 39/00, A61K 39/395, A61K 47/18, A61K 47/20
Agent:
Wilhelmus Johannes Wytenburg, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP14766786

3-ARYL-5-SUBSTITUTED-ISOQUINOLIN-1-ONE COMPOUNDS AND THEIR THERAPEUTIC USE

IPC classification:
A61P 35/00, C07D 217/24, C07D 401/10, C07D 401/14, C07D 413/10, C07D 413/14, C07D 471/08, A61K 31/472, A61K 31/4725
Agent:
Wilhelmus Johannes Wytenburg, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP14846876

PHOSPHORODIAMIDATE BACKBONE LINKAGE FOR OLIGONUCLEOTIDES

IPC classification:
A61P 35/00, C07H 19/10, C07H 19/20, C07H 21/04, C12N 15/113, A61K 31/7125, A61K 48/00
Agent:
Wilhelmus Johannes Wytenburg, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP13783630

DI-ISOPROPYL-PHOSPHINOYL-ALKANE (DAPA) COMPOUNDS AS TOPICAL AGENTS FOR THE TREATMENT OF SENSORY DISCOMFORT

IPC classification:
A61P 17/00, A61P 25/24, C07F 9/53, A61K 31/662
Agent:
Wilhelmus Johannes Wytenburg, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP14860025

POLYNUCLEOTIDE CONSTRUCTS HAVING DISULFIDE GROUPS

IPC classification:
C07F 9/02, C12P 19/34
Agent:
Wilhelmus Johannes Wytenburg, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP11715726

[((1R,2S,5R)-2-ISOPROPYL-5-METHYL-CYCLOHEXANECARBONYL)-AMINO]-ACETIC ACID ISOPROPYL ESTER AND RELATED COMPOUNDS AND THEIR USE IN THERAPY

IPC classification:
A61P 11/00, A61P 27/02, C07C 233/63, A61K 31/223
Agent:
Wilhelmus Johannes Wytenburg, Mewburn Ellis LLP
Status:
PATENT GRANTED
EP14866158

HYDRAZINYL-PYRROLO COMPOUNDS AND METHODS FOR PRODUCING A CONJUGATE

IPC classification:
A61K 31/4045
Agent:
Wilhelmus Johannes Wytenburg, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP14806358

1 -(5-TERT-BUTYL-2-ARYL-PYRAZOL-3-YL)-3-[2-FLUORO-4-[(3-OXO-4H-PYRIDO[2, 3-B]PYRAZIN-8-YL)OXY]PHENYL]UREA DERIVATIVES AS RAF INHIBITORS FOR THE TREATMENT OF CANCER

IPC classification:
A61P 35/00, C07D 471/04, A61K 31/4985
Applicant:
Cancer Research Technology Ltd
Agent:
Wilhelmus Johannes Wytenburg, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP15705417

HETEROARYL AMIDES AS INHIBITORS OF PROTEIN AGGREGATION

IPC classification:
A61P 25/28, C07D 417/14, A61K 31/4045
Agent:
Wilhelmus Johannes Wytenburg, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP15706282

PYRAZOLO[1,5-A]PYRIMIDINE-5,7-DIAMINE COMPOUNDS AS CDK INHIBITORS AND THEIR THERAPEUTIC USE

IPC classification:
A61P 35/00, C07D 487/04, A61K 31/519
Applicant:
Cancer Research Technology Ltd
Applicant:
Emory University
Agent:
Wilhelmus Johannes Wytenburg, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP15776318

METABOTROPIC GLUTAMATE RECEPTOR POSITIVE ALLOSTERIC MODULATORS (PAMS) AND USES THEREOF

IPC classification:
A61P 25/00, C07C 65/05, C07C 65/10, C07D 257/04, C07D 271/06, A61K 31/19, A61K 31/41, A61K 31/4245
Agent:
Wilhelmus Johannes Wytenburg, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP15803360

ANTI-HER2 ANTIBODY-MAYTANSINE CONJUGATES AND METHODS OF USE THEREOF

IPC classification:
A61K 47/50, A61K 31/4045
Agent:
Wilhelmus Johannes Wytenburg, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP15806027

METABOTROPIC GLUTAMATE RECEPTOR NEGATIVE ALLOSTERIC MODULATORS (NAMS) AND USES THEREOF

IPC classification:
C07D 217/06, C07D 249/08, C07D 277/20, C07D 285/08, C07D 417/04, A61K 31/4196, A61K 31/426, A61K 31/427, A61K 31/433
Agent:
Wilhelmus Johannes Wytenburg, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP15812491

CONJUGATES DERIVED FROM NON-STEROIDAL ANTI-INFLAMMATORY DRUGS AND METHODS OF USE THEREOF IN IMAGING

IPC classification:
A61K 47/50
Agent:
Wilhelmus Johannes Wytenburg, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP15819578

QUINUCLIDINE COMPOUNDS FOR MODULATING ALPHA7 -NICOTINIC ACETYLCHOLINE RECEPTOR ACTIVITY

IPC classification:
A61P 25/28, C07D 209/04, C07D 453/02, C07D 471/08, A61K 31/439
Agent:
Wilhelmus Johannes Wytenburg, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP15759570

FUMARATE ANALOGS AND USES THEREOF IN THE TREATMENT OF AN AUTOIMMUNE DISEASE OR AN INFLAMMATORY DISEASE

IPC classification:
A61P 17/06, A61P 37/00, C07D 257/04, C07D 401/04, C07D 403/12, C07D 405/04, C07D 405/06, A61K 31/41
Applicant:
Rigel Pharmaceuticals Inc
Agent:
Wilhelmus Johannes Wytenburg, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP15836833

NOVEL ULK1 INHIBITORS AND METHODS USING SAME

IPC classification:
A61P 27/00, A61P 35/00, A61K 31/505, A61K 31/506, A61K 31/517, A61K 31/519
Applicant:
Yale University
Agent:
Wilhelmus Johannes Wytenburg, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP15851085

INHIBITORS OF LOW MOLECULAR WEIGHT PROTEIN TYROSINE PHOSPHATASE AND USES THEREOF

IPC classification:
C07D 215/02, A61K 31/4706
Agent:
Wilhelmus Johannes Wytenburg, Mewburn Ellis LLP
Status:
Request for examination was made
EP15787849

METHOD OF TREATING CONDITIONS RELATED TO THE PGI2 RECEPTOR

IPC classification:
A61K 31/33
Agent:
Wilhelmus Johannes Wytenburg, Mewburn Ellis LLP
Status:
Request for examination was made
EP15817206

BICYCLOHETEROARYL-HETEROARYL-BENZOIC ACID COMPOUNDS AS RETINOIC ACID RECEPTOR BETA (RAR ) AGONISTS

IPC classification:
A61P 25/02, A61P 25/14, A61P 25/16, C07D 413/04, C07D 417/04, A61K 31/41
Agent:
Wilhelmus Johannes Wytenburg, Mewburn Ellis LLP
Status:
Request for examination was made
EP16700936

METHODS OF TREATING CONDITIONS RELATED TO THE S1P1 RECEPTOR

IPC classification:
A61P 29/00, A61P 37/00, A61K 31/473
Agent:
Wilhelmus Johannes Wytenburg, Mewburn Ellis LLP
Status:
Request for examination was made
EP15877341

COX-2-TARGETING, PLATINUM-CONTAINING CONJUGATES AND THEIR USE IN THE TREATMENT OF TUMORS AND CANCERS

IPC classification:
A61K 47/50
Agent:
Wilhelmus Johannes Wytenburg, Mewburn Ellis LLP
Status:
Request for examination was made
EP16703250

SUBSTITUTED TRIAZOLES AND METHODS RELATING THERETO

IPC classification:
A61P 25/08, A61P 25/14, C07D 249/04, C07D 401/12, C07D 403/04, C07D 405/04, A61K 31/4192, A61K 31/422, A61K 31/497, A61K 31/5377
Agent:
Grünecker Patent- und Rechtsanwälte PartG mbB
Agent:
Wilhelmus Johannes Wytenburg, Mewburn Ellis LLP
Status:
Request for examination was made
EP16704973

TETRAZOLONES AS CARBOXYLIC ACID BIOISOSTERES

IPC classification:
C07D 257/04, C07D 401/04, C07D 401/12, C07D 401/14, C07D 403/04, C07D 403/06, C07D 403/10, C07D 403/12, C07D 403/14, C07D 413/10, C07D 471/04, C07D 487/04, C07D 498/06, C07D 501/46, C07J 9/00
Applicant:
Rigel Pharmaceuticals Inc
Agent:
Wilhelmus Johannes Wytenburg, Mewburn Ellis LLP
Status:
Request for examination was made
EP16705684

[9,10-DIMETHOXY-3-(2-METHYLPROPYL)-1H,2H,3H,4H,6H,7H,11BH-PYRIDO-[2,1-A]ISOQUINOLIN-2-YL]METHANOL AND COMPOUNDS, COMPOSITIONS AND METHODS RELATING THERETO

IPC classification:
C07D 455/04
Agent:
Grünecker Patent- und Rechtsanwälte PartG mbB
Agent:
Wilhelmus Johannes Wytenburg, Mewburn Ellis LLP
Status:
Request for examination was made
EP15881407

ACTIVATED FORMYLGLYCINE-GENERATING ENZYMES AND METHODS OF PRODUCING AND USING THE SAME

IPC classification:
C12P 21/04, C12P 21/06
Agent:
Wilhelmus Johannes Wytenburg, Mewburn Ellis LLP
Status:
Request for examination was made
EP16704945

NOVEL N-ACYL-ARYLSULFONAMIDE DERIVATIVES AS AMINOACYL-TRNA SYNTHETASE INHIBITORS

IPC classification:
A61P 31/00, C07C 311/00, C07D 213/71, C07D 215/36, C07D 217/22, C07D 239/42, C07D 239/47, C07D 239/48, C07D 251/22, C07D 311/20, C07D 487/04, A61K 31/18, A61K 31/4402, A61K 31/47, A61K 31/505
Agent:
Wilhelmus Johannes Wytenburg, Mewburn Ellis LLP
Status:
Request for examination was made
EP15810646

N-(4-HYDROXY-4-METHZL-CYCLOHEXYL)-4-PHENYL-BENZENESULFONAMIDE AND N-(-4HYDROXY-4-METHYL-CYCLOHEXYL)-4-(2-PYRIDYL)-BENZENESULFONAMIDE COMPOUNDS AND THEIR THERAPEUTIC USE

IPC classification:
A61P 29/00, C07C 311/20, C07D 213/85, A61K 31/18, A61K 31/4418
Agent:
Wilhelmus Johannes Wytenburg, Mewburn Ellis LLP
Status:
Request for examination was made

Please Sign in to use this feature